B-type natriuretic peptide is a valuable adjunct for diagnosing, prognosticating, and guiding management in heart failure, though it should complement rather than replace clinical assessment.
No takes yet. Share an insight, caveat, or question.
Supports BNP for HF prognostication and guidance; leaves open confirmation in prospective RCTs before practice change.
Debra Isaac (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: